Atrium Therapeutics
RNA
#4478
Rank
NZ$4.20 B
Marketcap
NZ$26.68
Share price
-6.47%
Change (1 day)
-54.70%
Change (1 year)

Atrium Therapeutics (RNA) - Total debt

Total debt on the balance sheet as of December 2025 : NZ$6.33 Million

According to Atrium Therapeutics's latest financial reports the company's total debt is NZ$6.33 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Atrium Therapeutics - Total debt on balance sheet (from 2024 to 2025)

Total debt by year

Year Total debt Change
2025-12-31NZ$6.34 M-47.42%
2024-12-31NZ$12.05 M-22.59%
2023-12-31NZ$15.57 M